(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 103.44 | 88.97 | 75.99 | 16.3% | 36.1% |
Total Expenses | 87.35 | 87.70 | 63.94 | -0.4% | 36.6% |
Profit Before Tax | 16.09 | 1.27 | 12.05 | 1166.9% | 33.5% |
Tax | 3.77 | -0.01 | 2.73 | -37800.0% | 38.1% |
Profit After Tax | 12.32 | 1.28 | 9.32 | 862.5% | 32.2% |
Earnings Per Share | 19.90 | 2.10 | 15.10 | 847.6% | 31.8% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
NGL Fine Chem Ltd is a company engaged in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company primarily focuses on veterinary pharmaceuticals, catering to a niche market within the larger pharmaceutical industry. Its products are used in the treatment of animals, providing essential chemicals that form the core components of veterinary drugs. As of the latest information, there are no specific major developments available for the company within the provided data. NGL Fine Chem Ltd operates in an industry characterized by strict regulatory requirements and a high demand for quality assurance.
In the fourth quarter of fiscal year 2025 (Q4FY25), NGL Fine Chem Ltd reported a total income of ₹103.44 crores, representing a significant increase compared to both the previous quarter (Q3FY25) and the same quarter last year (Q4FY24). The quarter-over-quarter (QoQ) growth rate was 16.3%, while the year-over-year (YoY) growth rate stood at 36.1%. These figures indicate an upward trend in the company's revenue generation within the specified period, reflecting its growth trajectory over the past year. The increase in total income may be attributed to various factors such as higher sales volumes, increased product prices, or expansion into new markets, although specific drivers are not identified in the provided data.
The profitability metrics for NGL Fine Chem Ltd in Q4FY25 show substantial improvements. The company recorded a profit before tax of ₹16.09 crores, which marked a dramatic increase compared to ₹1.27 crores in Q3FY25 and ₹12.05 crores in Q4FY24. This reflects a QoQ growth of 1166.9% and a YoY growth of 33.5%. After accounting for taxes, the profit after tax amounted to ₹12.32 crores, a significant rise from both the previous quarter's ₹1.28 crores and the previous year's ₹9.32 crores, with a QoQ increase of 862.5% and a YoY increase of 32.2%. These figures suggest a strong financial performance in terms of profitability over the given periods. The earnings per share (EPS) also saw a remarkable increase to ₹19.90 in Q4FY25 from ₹2.10 in Q3FY25 and ₹15.10 in Q4FY24, indicating an 847.6% QoQ rise and a 31.8% YoY rise.
The financial data for NGL Fine Chem Ltd in Q4FY25 shows a total expense of ₹87.35 crores, which is slightly lower than the ₹87.70 crores reported in Q3FY25, reflecting a minor QoQ decrease of 0.4%. However, compared to Q4FY24, there was a significant YoY increase of 36.6% from ₹63.94 crores. The tax expense for the quarter was ₹3.77 crores, a notable shift from a nominal figure of -₹0.01 crores in Q3FY25 and an increase from ₹2.73 crores in Q4FY24, representing a YoY growth of 38.1%. The changes in these operating metrics, particularly the reduction in QoQ total expenses and the increase in tax expenses, may influence the overall financial outcomes for the company. The data suggests an overall expansion in operational scale and complexity over the past year.